Piper Sandler started coverage on shares of Beta Bionics (NASDAQ:BBNX – Get Free Report) in a report released on Monday, ...
Piper Sandler analyst David Amsellem reiterated a Hold rating on Supernus Pharmaceuticals (SUPN – Research Report) today and set a price target ...
Piper Sandler analyst David Westenberg maintained a Buy rating on NeoGenomics (NEO – Research Report) today and set a price target of $18.00.
In a report released today, Brent Bracelin from Piper Sandler maintained a Hold rating on Workday (WDAY – Research Report), with a price target ...
Nvidia (NASDAQ:NVDA) was in focus on Tuesday as investment firms Evercore ISI and Piper Sandler issued positive notes on the ...
In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Day One Biopharmaceuticals (DAWN – Research Report), ...
Insulet (NASDAQ:PODD – Get Free Report) had its price objective boosted by analysts at Piper Sandler from $285.00 to $310.00 ...
Nvidia (NASDAQ:NVDA) is once again at the center of Wall Street's attention as analysts set the stage for another strong ...
Trupanion (NASDAQ:TRUP – Free Report) had its target price trimmed by Piper Sandler from $57.00 to $52.00 in a research ...
Wix.com (NASDAQ:WIX – Get Free Report) had its price objective lifted by equities research analysts at Piper Sandler from ...
Piper Sandler downgraded shares of Amalgamated Financial (NASDAQ:AMAL – Free Report) from an overweight rating to a neutral rating in a research report released on Friday, Marketbeat.com reports. The ...
Nvidia (NASDAQ:NVDA) is in the spotlight ahead of its Q4 earnings, with Evercore ISI and Piper Sandler sticking to their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results